Medicinal application of long synthetic peptide technology (Q35907030)

11 August 2017

1 reference

title

Medicinal application of long synthetic peptide technology (English)

1 reference

11 August 2017

1

Giampietro Corradin

1 reference

11 August 2017

Francois Spertini

2

1 reference

PubMed ID

15461574

11 August 2017

Antonio Verdini

series ordinal

3

1 reference

PubMed ID

15461574

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

10

1 reference

11 August 2017

1629-1639

1 reference

High-performance liquid chromatographic purification of peptide hormones: ovine hypothalamic amunine (corticotropin releasing factor).

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Synthesis of native proteins by chemical ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Biotinylated synthetic chemokines: their use for the development of nonradioactive whole-cell binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments of Plasmodium falciparum Exp-1 by T-cells and plasma from human donors from African endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Conservation and heterogeneity of the glutamate-rich protein (GLURP) among field isolates and laboratory lines of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1629

10.1517/14712598.4.10.1629

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15461574